These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 9495298)
1. Phenotypic characterization of a novel long-QT syndrome mutation (R1623Q) in the cardiac sodium channel. Kambouris NG; Nuss HB; Johns DC; Tomaselli GF; Marban E; Balser JR Circulation; 1998 Feb; 97(7):640-4. PubMed ID: 9495298 [TBL] [Abstract][Full Text] [Related]
2. A revised view of cardiac sodium channel "blockade" in the long-QT syndrome. Kambouris NG; Nuss HB; Johns DC; Marbán E; Tomaselli GF; Balser JR J Clin Invest; 2000 Apr; 105(8):1133-40. PubMed ID: 10772658 [TBL] [Abstract][Full Text] [Related]
3. A de novo missense mutation of human cardiac Na+ channel exhibiting novel molecular mechanisms of long QT syndrome. Makita N; Shirai N; Nagashima M; Matsuoka R; Yamada Y; Tohse N; Kitabatake A FEBS Lett; 1998 Feb; 423(1):5-9. PubMed ID: 9506831 [TBL] [Abstract][Full Text] [Related]
5. Gating-dependent mechanisms for flecainide action in SCN5A-linked arrhythmia syndromes. Viswanathan PC; Bezzina CR; George AL; Roden DM; Wilde AA; Balser JR Circulation; 2001 Sep; 104(10):1200-5. PubMed ID: 11535580 [TBL] [Abstract][Full Text] [Related]
6. Congenital long-QT syndrome caused by a novel mutation in a conserved acidic domain of the cardiac Na+ channel. Wei J; Wang DW; Alings M; Fish F; Wathen M; Roden DM; George AL Circulation; 1999 Jun; 99(24):3165-71. PubMed ID: 10377081 [TBL] [Abstract][Full Text] [Related]
7. Intrinsic mechanism of the enhanced rate-dependent QT shortening in the R1623Q mutant of the LQT3 syndrome. Oginosawa Y; Nagatomo T; Abe H; Makita N; Makielski JC; Nakashima Y Cardiovasc Res; 2005 Jan; 65(1):138-47. PubMed ID: 15621041 [TBL] [Abstract][Full Text] [Related]
8. A novel mutation in SCN5A, delQKP 1507-1509, causing long QT syndrome: role of Q1507 residue in sodium channel inactivation. Keller DI; Acharfi S; Delacrétaz E; Benammar N; Rotter M; Pfammatter JP; Fressart V; Guicheney P; Chahine M J Mol Cell Cardiol; 2003 Dec; 35(12):1513-21. PubMed ID: 14654377 [TBL] [Abstract][Full Text] [Related]
9. Differential modulation of late sodium current by protein kinase A in R1623Q mutant of LQT3. Tsurugi T; Nagatomo T; Abe H; Oginosawa Y; Takemasa H; Kohno R; Makita N; Makielski JC; Otsuji Y Life Sci; 2009 Mar; 84(11-12):380-7. PubMed ID: 19167409 [TBL] [Abstract][Full Text] [Related]
10. Characterization of human cardiac Na+ channel mutations in the congenital long QT syndrome. Wang DW; Yazawa K; George AL; Bennett PB Proc Natl Acad Sci U S A; 1996 Nov; 93(23):13200-5. PubMed ID: 8917568 [TBL] [Abstract][Full Text] [Related]
11. Molecular mechanism for an inherited cardiac arrhythmia. Bennett PB; Yazawa K; Makita N; George AL Nature; 1995 Aug; 376(6542):683-5. PubMed ID: 7651517 [TBL] [Abstract][Full Text] [Related]
12. Mexiletine rescues a mixed biophysical phenotype of the cardiac sodium channel arising from the SCN5A mutation, N406K, found in LQT3 patients. Hu RM; Tester DJ; Li R; Sun T; Peterson BZ; Ackerman MJ; Makielski JC; Tan BH Channels (Austin); 2018; 12(1):176-186. PubMed ID: 29983085 [TBL] [Abstract][Full Text] [Related]
13. A novel mutation L619F in the cardiac Na+ channel SCN5A associated with long-QT syndrome (LQT3): a role for the I-II linker in inactivation gating. Wehrens XH; Rossenbacker T; Jongbloed RJ; Gewillig M; Heidbüchel H; Doevendans PA; Vos MA; Wellens HJ; Kass RS Hum Mutat; 2003 May; 21(5):552. PubMed ID: 12673799 [TBL] [Abstract][Full Text] [Related]
14. Trafficking defects and gating abnormalities of a novel SCN5A mutation question gene-specific therapy in long QT syndrome type 3. Ruan Y; Denegri M; Liu N; Bachetti T; Seregni M; Morotti S; Severi S; Napolitano C; Priori SG Circ Res; 2010 Apr; 106(8):1374-83. PubMed ID: 20339117 [TBL] [Abstract][Full Text] [Related]
15. Malignant perinatal variant of long-QT syndrome caused by a profoundly dysfunctional cardiac sodium channel. Wang DW; Crotti L; Shimizu W; Pedrazzini M; Cantu F; De Filippo P; Kishiki K; Miyazaki A; Ikeda T; Schwartz PJ; George AL Circ Arrhythm Electrophysiol; 2008 Dec; 1(5):370-8. PubMed ID: 19808432 [TBL] [Abstract][Full Text] [Related]
16. A de novo missense mutation (R1623Q) of the SCN5A gene in a Japanese girl with sporadic long QT sydrome. Mutations in brief no. 140. Online. Yamagishi H; Furutani M; Kamisago M; Morikawa Y; Kojima Y; Hino Y; Furutani Y; Kimura M; Imamura S; Takao A; Momma K; Matsuoka R Hum Mutat; 1998; 11(6):481. PubMed ID: 10200053 [TBL] [Abstract][Full Text] [Related]
17. A novel LQT3 mutation implicates the human cardiac sodium channel domain IVS6 in inactivation kinetics. Groenewegen WA; Bezzina CR; van Tintelen JP; Hoorntje TM; Mannens MM; Wilde AA; Jongsma HJ; Rook MB Cardiovasc Res; 2003 Mar; 57(4):1072-8. PubMed ID: 12650885 [TBL] [Abstract][Full Text] [Related]
18. Gating Properties of Mutant Sodium Channels and Responses to Sodium Current Inhibitors Predict Mexiletine-Sensitive Mutations of Long QT Syndrome 3. Li G; Woltz RL; Wang CY; Ren L; He PX; Yu SD; Liu XQ; Yarov-Yarovoy V; Hu D; Chiamvimonvat N; Wu L Front Pharmacol; 2020; 11():1182. PubMed ID: 32848785 [TBL] [Abstract][Full Text] [Related]
19. Novel LQT-3 mutation affects Na+ channel activity through interactions between alpha- and beta1-subunits. An RH; Wang XL; Kerem B; Benhorin J; Medina A; Goldmit M; Kass RS Circ Res; 1998 Jul; 83(2):141-6. PubMed ID: 9686753 [TBL] [Abstract][Full Text] [Related]
20. A common SCN5A polymorphism modulates the biophysical defects of SCN5A mutations. Shinlapawittayatorn K; Du XX; Liu H; Ficker E; Kaufman ES; Deschênes I Heart Rhythm; 2011 Mar; 8(3):455-62. PubMed ID: 21109022 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]